Roche’s (JOBS) Actemra Successful in Arthritis Study; Meets Primary Endpoint in Phase III Study

Reuters -- A treatment which could offer relief for thousands of sufferers of a type of childhood arthritis came a step nearer approval on Friday as Roche (ROG.VX) said its Actemra drug had been successful in a late-stage clinical trial.